Adaptmet
@adaptmet.bsky.social
A Doctoral Network (DN) funded by the European Commission (GA 101169223) aimed at advancing our understanding of metastasis by training 16 researchers specialised in this field.
Heads up! Small change to Friday’s workshop: Dr. Sebastian Carotta can’t make it, but we’re thrilled to have Dr. Victoria Sanz-Moreno (ICR) stepping in to talk about “Biomechanical hallmarks & vulnerabilities of metastatic & therapy resistant cancer cells” See you there! @vickysanzmoreno.bsky.social
November 12, 2025 at 8:20 AM
Heads up! Small change to Friday’s workshop: Dr. Sebastian Carotta can’t make it, but we’re thrilled to have Dr. Victoria Sanz-Moreno (ICR) stepping in to talk about “Biomechanical hallmarks & vulnerabilities of metastatic & therapy resistant cancer cells” See you there! @vickysanzmoreno.bsky.social
Next week the ADAPTMET consortium meets in Barcelona for our 1st Annual Meeting! 👋
A full week of training, science & a workshop on Frontiers in Metastasis Research — advancing our DCs’ skills and shaping the next generation of European metastasis researchers.
A full week of training, science & a workshop on Frontiers in Metastasis Research — advancing our DCs’ skills and shaping the next generation of European metastasis researchers.
November 6, 2025 at 11:05 AM
Next week the ADAPTMET consortium meets in Barcelona for our 1st Annual Meeting! 👋
A full week of training, science & a workshop on Frontiers in Metastasis Research — advancing our DCs’ skills and shaping the next generation of European metastasis researchers.
A full week of training, science & a workshop on Frontiers in Metastasis Research — advancing our DCs’ skills and shaping the next generation of European metastasis researchers.
📢Frontiers in Metastasis Research Workshop!
🗓️ 14 NOV 2025 (9:00–12:30) in Barcelona. Intensive session on metastatic adaptation, therapeutic resistance, and TME.
Open event. Full Agenda & Reg: irbbarcelona.org/adaptmet-workshop
#CancerResearch #Metastasis #TME #Oncology
🗓️ 14 NOV 2025 (9:00–12:30) in Barcelona. Intensive session on metastatic adaptation, therapeutic resistance, and TME.
Open event. Full Agenda & Reg: irbbarcelona.org/adaptmet-workshop
#CancerResearch #Metastasis #TME #Oncology
October 29, 2025 at 2:01 PM
📢Frontiers in Metastasis Research Workshop!
🗓️ 14 NOV 2025 (9:00–12:30) in Barcelona. Intensive session on metastatic adaptation, therapeutic resistance, and TME.
Open event. Full Agenda & Reg: irbbarcelona.org/adaptmet-workshop
#CancerResearch #Metastasis #TME #Oncology
🗓️ 14 NOV 2025 (9:00–12:30) in Barcelona. Intensive session on metastatic adaptation, therapeutic resistance, and TME.
Open event. Full Agenda & Reg: irbbarcelona.org/adaptmet-workshop
#CancerResearch #Metastasis #TME #Oncology
🎉 Today, we gathered online for the #AdaptMet Kick-Off Meeting! A fantastic start to this journey, bringing together top researchers & partners to train the next generation of metastasis experts. Exciting discussions & collaborations ahead—stay tuned! 🔬✨ #CancerResearch
February 10, 2025 at 1:41 PM
🎉 Today, we gathered online for the #AdaptMet Kick-Off Meeting! A fantastic start to this journey, bringing together top researchers & partners to train the next generation of metastasis experts. Exciting discussions & collaborations ahead—stay tuned! 🔬✨ #CancerResearch
With this hand-crafted itinerary combining cutting-edge research, global experiences, and impactful training, we want to make this dream program a reality with the best doctoral candidates & help them become tomorrow's leaders in metastasis research. Interested? Apply today: adaptmet.eu/recruitment
December 20, 2024 at 12:14 PM
With this hand-crafted itinerary combining cutting-edge research, global experiences, and impactful training, we want to make this dream program a reality with the best doctoral candidates & help them become tomorrow's leaders in metastasis research. Interested? Apply today: adaptmet.eu/recruitment
DCs will lead and organise a conference in Brussels to invite peers, experts and several stakeholders to showcase their latest research and engage meaningfully with the community. The Adaptmet final conference is bound to be a showstopper event in the metastasis research field!
December 20, 2024 at 12:14 PM
DCs will lead and organise a conference in Brussels to invite peers, experts and several stakeholders to showcase their latest research and engage meaningfully with the community. The Adaptmet final conference is bound to be a showstopper event in the metastasis research field!
Three mid-yearly schools will further augment the training and networking experience for Adaptmet DCs:
✅Science Writing by @scienseed.com
✅Intro. to Clinical Research by Solti
✅Innovation: Take ideas to market by @irbbarcelona.org Innovation Department
✅Science Writing by @scienseed.com
✅Intro. to Clinical Research by Solti
✅Innovation: Take ideas to market by @irbbarcelona.org Innovation Department
December 20, 2024 at 12:13 PM
Three mid-yearly schools will further augment the training and networking experience for Adaptmet DCs:
✅Science Writing by @scienseed.com
✅Intro. to Clinical Research by Solti
✅Innovation: Take ideas to market by @irbbarcelona.org Innovation Department
✅Science Writing by @scienseed.com
✅Intro. to Clinical Research by Solti
✅Innovation: Take ideas to market by @irbbarcelona.org Innovation Department
Four Annual Meetings will bring the network together and help DCs connect with peers, supervisors and top scientists to discuss their research and collaborate. Adaptmet associated partners @hfpconsulting.bsky.social @scienseed.com
will enhance the experience with tailor-made training sessions.
will enhance the experience with tailor-made training sessions.
December 20, 2024 at 12:12 PM
Four Annual Meetings will bring the network together and help DCs connect with peers, supervisors and top scientists to discuss their research and collaborate. Adaptmet associated partners @hfpconsulting.bsky.social @scienseed.com
will enhance the experience with tailor-made training sessions.
will enhance the experience with tailor-made training sessions.
With personalised plans, Adaptmet DCs will access top-tier workshops and courses for specific training in research methods, technical expertise, and professional skills in their host and secondment institutions to ensure that they are ready to tackle their research goals and beyond.
December 20, 2024 at 12:09 PM
With personalised plans, Adaptmet DCs will access top-tier workshops and courses for specific training in research methods, technical expertise, and professional skills in their host and secondment institutions to ensure that they are ready to tackle their research goals and beyond.
Through Secondments & Short Stays, Adaptmet DCs will capitalize on the leading EU network on metastasis research and enhance their experience, skills and career aspirations through meaningful exchanges among the collaborating institutions.
December 20, 2024 at 12:09 PM
Through Secondments & Short Stays, Adaptmet DCs will capitalize on the leading EU network on metastasis research and enhance their experience, skills and career aspirations through meaningful exchanges among the collaborating institutions.
Looking for a PhD? Follow this🧵 to know how Adaptmet's innovative training will combine continuous training in cutting-edge metastasis research with custom-made network-wide events to enhance, accelerate & elevate the skills, capacities & network of our doctoral candidates (DCs)
December 20, 2024 at 12:06 PM
Looking for a PhD? Follow this🧵 to know how Adaptmet's innovative training will combine continuous training in cutting-edge metastasis research with custom-made network-wide events to enhance, accelerate & elevate the skills, capacities & network of our doctoral candidates (DCs)
Remember, the deadline for applications is the 9th of January 2025! Apply now at adaptmet.eu/recruitment/ to be a part of our renowned scientific network at the forefront of metastasis research 🧬🔬🗓️
December 10, 2024 at 2:20 PM
Remember, the deadline for applications is the 9th of January 2025! Apply now at adaptmet.eu/recruitment/ to be a part of our renowned scientific network at the forefront of metastasis research 🧬🔬🗓️
And finally, DC16 will explore the mechanisms of resistance to Fulvestrant plus Ribociclib in ER+ metastatic breast cancer under the supervision of Momo Bentires-Alj @momobentires.bsky.social at the University of Basel @unibas.ch
December 10, 2024 at 2:17 PM
And finally, DC16 will explore the mechanisms of resistance to Fulvestrant plus Ribociclib in ER+ metastatic breast cancer under the supervision of Momo Bentires-Alj @momobentires.bsky.social at the University of Basel @unibas.ch
Johanna Joyce @johannajoyce.bsky.social at the University of Lausanne @unil.bsky.social will supervise DC15 towards investigating the interplay between immune cells and the vasculature in brain metastasis
December 10, 2024 at 2:15 PM
Johanna Joyce @johannajoyce.bsky.social at the University of Lausanne @unil.bsky.social will supervise DC15 towards investigating the interplay between immune cells and the vasculature in brain metastasis
Victoria Sanz-Moreno @vickysanzmoreno.bsky.social at the Institute of Cancer Research will guide DC14 on their efforts to understand triple-negative breast cancer cytoskeletal dynamics and control of the tumour metastasis microenvironment
December 10, 2024 at 2:14 PM
Victoria Sanz-Moreno @vickysanzmoreno.bsky.social at the Institute of Cancer Research will guide DC14 on their efforts to understand triple-negative breast cancer cytoskeletal dynamics and control of the tumour metastasis microenvironment
DC13 will work on sub gene-level dissection of cell-cell interactions in the cancer metastasis microenvironment under the supervision of Federico De Masi at ZS Associates
December 10, 2024 at 2:10 PM
DC13 will work on sub gene-level dissection of cell-cell interactions in the cancer metastasis microenvironment under the supervision of Federico De Masi at ZS Associates
Sebastian Carotta at Boehringer Ingelheim will oversee DC12's work on the induction of immunogenic cell death in cancer cells to initiate a systemic antitumor immune response
December 10, 2024 at 2:09 PM
Sebastian Carotta at Boehringer Ingelheim will oversee DC12's work on the induction of immunogenic cell death in cancer cells to initiate a systemic antitumor immune response
DC11 will identify circulating tumour DNA (ctDNA)-based biomarkers for predicting response to treatment in metastatic HER2-positive (HER2+) and triple-negative breast cancer under Aleix Prat @prat-aleix-md.bsky.social at IDIBAPS @idibaps.bsky.social
December 10, 2024 at 2:08 PM
DC11 will identify circulating tumour DNA (ctDNA)-based biomarkers for predicting response to treatment in metastatic HER2-positive (HER2+) and triple-negative breast cancer under Aleix Prat @prat-aleix-md.bsky.social at IDIBAPS @idibaps.bsky.social
DC8 will define the role of vascular cells in bone metastasis at the Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social under the supervision of Mariona Graupera @grauperalab.bsky.social
December 10, 2024 at 2:06 PM
DC8 will define the role of vascular cells in bone metastasis at the Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social under the supervision of Mariona Graupera @grauperalab.bsky.social
Karin de Visser at The Netherlands Cancer Institute will supervise DC6 and their research into dissecting how the genetic makeup of mammary tumours impacts the immune milieu within pre-metastatic and metastatic niches
December 10, 2024 at 2:05 PM
Karin de Visser at The Netherlands Cancer Institute will supervise DC6 and their research into dissecting how the genetic makeup of mammary tumours impacts the immune milieu within pre-metastatic and metastatic niches
DC5 will research molecular mechanisms of immune responses and evasion in metastatic colonisation under the supervision of Anna Christina Obenauf @obenaufa.bsky.social at the Institute of Molecular Pathology @impvienna.bsky.social
December 10, 2024 at 2:03 PM
DC5 will research molecular mechanisms of immune responses and evasion in metastatic colonisation under the supervision of Anna Christina Obenauf @obenaufa.bsky.social at the Institute of Molecular Pathology @impvienna.bsky.social
Kristian Pietras @kpietraslab.bsky.social at Lund University @lunduniversity.bsky.social will oversee DC4 who will work on the suppression of metastatic dissemination through precision targeting of cancer-associated fibroblast niches
December 10, 2024 at 2:02 PM
Kristian Pietras @kpietraslab.bsky.social at Lund University @lunduniversity.bsky.social will oversee DC4 who will work on the suppression of metastatic dissemination through precision targeting of cancer-associated fibroblast niches
Adaptmet coordinator Roger Gomis from IRB Barcelona @irbbarcelona.bsky.social will supervise DC3's work on breast cancer metastasis cell fate mapping and DC7's project on drug-tolerant metastasis persister cells in breast cancer latency
December 10, 2024 at 2:01 PM
Adaptmet coordinator Roger Gomis from IRB Barcelona @irbbarcelona.bsky.social will supervise DC3's work on breast cancer metastasis cell fate mapping and DC7's project on drug-tolerant metastasis persister cells in breast cancer latency
DC2 will discover the gene regulatory networks controlling epithelial-mesenchymal transition in metastasis and DC9 will unravel the role of NR2F family members in metastasis latency and expansion supervised by @cedric-blanpain.bsky.social at Univ Libre de Bruxelles & Cancer State Therapeutics
December 10, 2024 at 1:59 PM
DC2 will discover the gene regulatory networks controlling epithelial-mesenchymal transition in metastasis and DC9 will unravel the role of NR2F family members in metastasis latency and expansion supervised by @cedric-blanpain.bsky.social at Univ Libre de Bruxelles & Cancer State Therapeutics
Sakari Vanharanta @svanharanta.bsky.social from the University of Helsinki @helsinkiuni.bsky.social will supervise two positions: DC1 who will work on cell states associated with early metastatic colonisation and DC10, who will research minimal residual disease in metastatic latency
December 10, 2024 at 1:56 PM
Sakari Vanharanta @svanharanta.bsky.social from the University of Helsinki @helsinkiuni.bsky.social will supervise two positions: DC1 who will work on cell states associated with early metastatic colonisation and DC10, who will research minimal residual disease in metastatic latency